These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 21089601)
1. [Integrative in silico approach to assess the druggability of protein-protein interactions]. Sugaya N Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1641-6. PubMed ID: 21089601 [No Abstract] [Full Text] [Related]
2. Databases of protein-protein interactions and their use in drug discovery. Fuentes G; Oyarzabal J; Rojas AM Curr Opin Drug Discov Devel; 2009 May; 12(3):358-66. PubMed ID: 19396737 [TBL] [Abstract][Full Text] [Related]
3. High-throughput identification of transient extracellular protein interactions. Wright GJ; Martin S; Bushell KM; Söllner C Biochem Soc Trans; 2010 Aug; 38(4):919-22. PubMed ID: 20658977 [TBL] [Abstract][Full Text] [Related]
4. [From systematic analysis of protein interaction networks to chemical biology]. Natsume T Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1628-33. PubMed ID: 21089599 [No Abstract] [Full Text] [Related]
5. The evolving role of molecular diversity in drug discovery. Marcaurelle LA; Foley MA Curr Opin Chem Biol; 2010 Jun; 14(3):285-8. PubMed ID: 20472491 [No Abstract] [Full Text] [Related]
6. Label-free screening of drug-protein interactions by time-resolved Fourier transform infrared spectroscopic assays exemplified by Ras interactions. Kötting C; Suveyzdis Y; Bojja RS; Metzler-Nolte N; Gerwert K Appl Spectrosc; 2010 Sep; 64(9):967-72. PubMed ID: 20828432 [TBL] [Abstract][Full Text] [Related]
7. Protein-protein interactions: Tools for the search. Bonetta L Nature; 2010 Dec; 468(7325):852. PubMed ID: 21150999 [No Abstract] [Full Text] [Related]
8. Structure-based evaluation of in silico predictions of protein-protein interactions using Comparative Docking. Cockell SJ; Oliva B; Jackson RM Bioinformatics; 2007 Mar; 23(5):573-81. PubMed ID: 17237047 [TBL] [Abstract][Full Text] [Related]
9. Interaction networks: from protein functions to drug discovery. A review. Chautard E; Thierry-Mieg N; Ricard-Blum S Pathol Biol (Paris); 2009 Jun; 57(4):324-33. PubMed ID: 19070972 [TBL] [Abstract][Full Text] [Related]
12. Predicting protein complexes by data integration of different types of interactions. Tan PP; Dargahi D; Pio F Int J Comput Biol Drug Des; 2010; 3(1):19-30. PubMed ID: 20693608 [TBL] [Abstract][Full Text] [Related]
13. Fragment screening to predict druggability (ligandability) and lead discovery success. Edfeldt FN; Folmer RH; Breeze AL Drug Discov Today; 2011 Apr; 16(7-8):284-7. PubMed ID: 21315179 [No Abstract] [Full Text] [Related]
14. Implications for domain fusion protein-protein interactions based on structural information. Chia JM; Kolatkar PR BMC Bioinformatics; 2004 Oct; 5():161. PubMed ID: 15504241 [TBL] [Abstract][Full Text] [Related]
15. A computationally guided protein-interaction screen uncovers coiled-coil interactions involved in vesicular trafficking. Zhang H; Chen J; Wang Y; Peng L; Dong X; Lu Y; Keating AE; Jiang T J Mol Biol; 2009 Sep; 392(1):228-41. PubMed ID: 19591838 [TBL] [Abstract][Full Text] [Related]
16. Beta-lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein protein interactions. Galarneau A; Primeau M; Trudeau LE; Michnick SW Nat Biotechnol; 2002 Jun; 20(6):619-22. PubMed ID: 12042868 [TBL] [Abstract][Full Text] [Related]